Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GRIESE EU' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Griese, EU; Ilett, KF; Kitteringham, NR; Eichelbaum, M; Powell, H; Spargo, RM; LeSouef, PN; Musk, AW; Minchin, RF
      Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia

      PHARMACOGENETICS
    2. Lohmann, PL; Rao, ML; Ludwig, M; Griese, EU; Zanger, UM; Morike, K; Maier, W; Bagli, M
      Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    3. Friedrich, U; Schwab, M; Griese, EU; Fritz, P; Klotz, U
      Telomeres in neonates: New insights in fetal hematopoiesis

      PEDIATRIC RESEARCH
    4. Raimundo, S; Fischer, R; Eichelbaum, M; Griese, EU; Schwab, M; Zanger, UM
      Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

      PHARMACOGENETICS
    5. Friedrich, U; Griese, EU; Schwab, M; Fritz, P; Thon, KP; Klotz, U
      Telomere length in different tissues of elderly patients

      MECHANISMS OF AGEING AND DEVELOPMENT
    6. Griese, EU; Asante-Poku, S; Ofori-Adjei, D; Mikus, G; Eichelbaum, M
      Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population

      PHARMACOGENETICS
    7. Griese, EU; Lapple, F; Eichelbaum, M
      Detection of CYP2C19 alleles*1,*2 and*3 by multiplex polymerase chain reaction

      PHARMACOGENETICS
    8. Jorge, LF; Eichelbaum, M; Griese, EU; Inaba, T; Arias, TD
      Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations

      PHARMACOGENETICS
    9. Ammon, S; Hofmann, U; Griese, EU; Gugeler, N; Mikus, G
      Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Schwab, M; Seyringer, E; Brauer, RB; Hellinger, A; Griese, EU
      Fatal MDMA intoxication

      LANCET
    11. GRIESE EU; ZANGER UM; BRUDERMANNS U; GAEDIGK A; MIKUS G; MORIKE K; STUVEN T; EICHELBAUM M
      ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION

      Pharmacogenetics
    12. Mikus, G; Morike, K; Griese, EU; Klotz, U
      Relevance of deficient CYP2D6 in opiate dependence

      PHARMACOGENETICS
    13. GROZINGER M; HARTTER S; HIEMKE C; GRIESE EU; ROSCHKE J
      INTERACTION OF MODAFINIL AND CLOMIPRAMINE AS COMEDICATION IN A NARCOLEPTIC PATIENT

      Clinical neuropharmacology
    14. LAEPPLE F; GRIESE EU; ZANGER U; THON KP; EICHELBAUM M
      ANALYSIS OF CYP2C8, CYP2C9, CYP2C18 AND CYP2C19 MESSENGER-RNA EXPRESSION IN HUMAN LIVER, SMALL-INTESTINE, SKIN AND LEUKOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    15. GRIESE EU; GAEDIGK A; MORIKE; MIKUS G; ZANGER U; EICHELBAUM M
      CATALYTIC IN-VIVO FUNCTION OF CYP2D6 IN RELATION TO THE GENOTYPE

      Naunyn-Schmiedeberg's archives of pharmacology
    16. STUVEN T; GRIESE EU; KROEMER HK; EICHELBAUM M; ZANGER UM
      RAPID DETECTION OF CYP2D6 NULL ALLELES BY LONG DISTANCE-POLYMERASE AND MULTIPLEX-POLYMERASE CHAIN-REACTION

      Pharmacogenetics
    17. KIVISTO KT; BOOKJANS G; FROMM MF; GRIESE EU; MUNZEL P; KROEMER HK
      EXPRESSION OF CYP3A4, CYP3A5 AND CYP3A7 IN HUMAN DUODENAL TISSUE

      British journal of clinical pharmacology
    18. KIVISTO KT; GRIESE EU; FRITZ P; LINDER A; HAKKOLA J; RAUNIO H; BEAUNE P; KROEMER HK
      EXPRESSION OF CYTOCHROME-P-450 3A ENZYMES IN HUMAN LUNG - A COMBINED RT-PCR AND IMMUNOHISTOCHEMICAL ANALYSIS OF NORMAL TISSUE AND LUNG-TUMORS

      Naunyn-Schmiedeberg's archives of pharmacology
    19. MORIKE K; MAGADUM S; METTANG T; GRIESE EU; MACHLEIDT C; KUHLMANN U
      PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY

      Journal of internal medicine
    20. FROMM MF; HOFMANN U; GRIESE EU; MIKUS G
      DIHYDROCODEINE - A NEW OPIOID SUBSTRATE FOR THE POLYMORPHIC CYP2D6 INHUMANS

      Clinical pharmacology and therapeutics
    21. EVERT B; GRIESE EU; EICHELBAUM M
      CLONING AND SEQUENCING OF A NEW NONFUNCTIONAL CYP2D6 ALLELE - DELETION OF T-1795 IN EXON-3 GENERATES A PREMATURE STOP CODON

      Pharmacogenetics
    22. BOCK KW; SCHRENK D; FORSTER A; GRIESE EU; MORIKE K; BROCKMEIER D; EICHELBAUM M
      THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, ANDPARACETAMOL AS PROBES

      Pharmacogenetics
    23. GRUNEBACH F; GRIESE EU; SCHUMACHER K
      COMPETITIVE NESTED POLYMERASE CHAIN-REACTION FOR QUANTIFICATION OF HUMAN MDR1 GENE-EXPRESSION

      Journal of cancer research and clinical oncology
    24. EVERT B; GRIESE EU; EICHELBAUM M
      A MISSENSE MUTATION IN EXON-6 OF THE CYP2D6 GENE LEADING TO A HISTIDINE-324 TO PROLINE EXCHANGE IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE OF SPARTEINE

      Naunyn-Schmiedeberg's archives of pharmacology
    25. ARIAS TD; JORGE LF; GRIESE EU; INABA T; EICHELBAUM M
      POLYMORPHIC N-ACETYLTRANSFERASE (NAT2) IN AMERINDIAN POPULATIONS OF PANAMA AND COLOMBIA - HIGH-FREQUENCIES OF POINT MUTATION 857A, AS FOUNDIN ALLELE S3 M3

      Pharmacogenetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 00:31:33